H. Köstering

发表

A novel 5′-upstream mutation in the factor X11 gene is associated with a Taql restriction site in an Alu repeat in factor X11-deficient patients

S. Hofferbert, Jens Müller, H. Köstering, 1996, Human Genetics.

Adult respiratory distress syndrome (ARDS): experimental models with elastase and thrombin infusion in pigs.

W. Hörl, G. Schlag, H. Burchardi, 1984, Advances in experimental medicine and biology.

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

K. Karsch, V. Wiegand, H. Köstering, 1979, Clinical cardiology.

[Intracoronary application of streptokinase in acute myocardial infarction and non-stable angina pectoris (author's transl)].

P. Rentrop, K. Karsch, H. Köstering, 2008, Deutsche medizinische Wochenschrift.

High dose intravenous streptokinase in acute myocardial infarction

U. Tebbe, K. Neuhaus, H. Kreuzer, 1983, Clinical cardiology.

[Reopening of infarct-occluded vessel by transluminal recanalisation and intracoronary streptokinase application (author's transl)].

P. Rentrop, K. Karsch, V. Wiegand, 1979, Deutsche medizinische Wochenschrift.

Effects of Coronary Artery Reperfusion on Myocardial Infarct Size and Survival in Conscious Dogs

P. Rentrop, K. Karsch, H. Köstering, 2005 .

The Effect of Intracoronary Nitroglycerin in Acute Myocardial Infarction

P. Rentrop, K. Karsch, H. Köstering, 1981 .

Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL.

V. Armstrong, P. Schuff-Werner, D. Seidel, 1989, Atherosclerosis.

Comparison of unfractionated heparin and low molecular weight heparin during long-term use in chronic haemodialysis and haemofiltration patients.

H. Köstering, J. Schrader, F. Scheler, 1986, Haemostasis.

Alterations of Blood Coagulation in Patients with Acute Renal Failure

H. Köstering, J. Schrader, F. Scheler, 1985 .

[The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].

H. Köstering, B. Bandura, H. A. Merten, 1985, Arzneimittel-Forschung.

Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration.

V. Armstrong, R. Muche, D. Seidel, 1988, Kidney international.

Blood coagulation studies in domestic pigs (Hanover breed) and minipigs (Goettingen breed)

H. Köstering, K. Nebendahl, W. Holtz, 1983, Laboratory animals.

Low molecular weight heparin in hemodialysis and hemofiltration patients.

V. Armstrong, H. Köstering, J. Schrader, 1985, Kidney international.

[Studies on changes in blood coagulation during and after operations with the help of the heart lung machine (author's transl)].

H. Köstering, P. Kirchhoff, J. Koncz, 1973, Thoraxchirurgie, vaskulare Chirurgie.

Factor XII deficiency is strongly associated with primary recurrent abortions.

G. Emons, P. Burfeind, H. Köstering, 2003, Fertility and Sterility.

Fibrinolytic activity in renal venous blood in man

U. Tebbe, K. Neuhaus, H. Köstering, 1986, Klinische Wochenschrift.

Continuous intravenous infusion of elastase in normal and agranulocytic minipigs--effects on the lungs and the blood coagulation system.

H. Burchardi, H. Köstering, T. Stokke, 1986, Resuscitation.

Determination of Soluble Fibrin by Turbidimetry of its Protamine Sulphate-Induced Paracoagulation

H. Köstering, J. Wieding, G. Eisinger, 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[Plasmapheresis: First clinical results in malignant tumors].

P. Schuff-Werner, H. Köstering, G. Nagel, 1981, Schweizerische medizinische Wochenschrift.

Anticoagulation in Continuous Arteriovenous Hemofiltration

T. Eisenhauer, H. Köstering, J. Schrader, 1985 .

[Therapy of acute experimental pancreatitis with the antifibrinolytic drug PAMBA (author's transl)].

P. Lankisch, K. Winckler, H. Koop, 1977, Zeitschrift fur Gastroenterologie.

[Diagnosis of disseminated intravascular coagulation: the value of soluble fibrin, D-dimers and fibrin(ogen) split products].

H. Köstering, J. Wieding, G. Eisinger, 1989, Klinische Wochenschrift.

[Antithrombin III substitution in dialysis-dependent renal insufficiency].

H. Köstering, J. Schrader, F. Scheler, 2008, Deutsche medizinische Wochenschrift.

[Anticoagulant treatment for avoiding the shunt-induced thrombosis in patients on hemodialysis].

H. Köstering, F. Scheler, W. Wigger, 1970, Medizinische Klinik.

Selective continuous extracorporal elimination of low-density lipoproteins with heparin at acidic pH.

V. Armstrong, H. Wieland, D. Seidel, 1983, Transactions - American Society for Artificial Internal Organs.

Alterations of clotting factors and platelets during hemofiltration.

D. Matthaei, H. Köstering, E. Quellhorst, 1977, Journal of dialysis.

Selective Intracoronary Thrombolysis in Acute Myocardial Infarction and Unstable Angina Pectoris

P. Rentrop, K. Karsch, H. Köstering, 1981, Circulation.

[Effect of Expafusion (HES 40/0.5) on the corpuscular elements of blood and inhibitors of blood coagulation].

H. Köstering, J. Giffhorn, B. Negendank-Damenz, 1985, Infusionstherapie und klinische Ernährung.

Retention Test Homburg To Monitor the Adhesive Properties of von Willebrand Factor after Substitution or Desmopressin Therapy

H. Köstering, C. Wermes, J. Matern, 2005, Seminars in thrombosis and hemostasis.

Diagnostik der disseminierten intravasalen Gerinnung: Aussagekraft von löslichem Fibrin, D-Dimeren und Fibrin(ogen)-Spaltprodukten

H. Köstering, J. U. Wieding, H. Köstering, 1989, Klinische Wochenschrift.